Apollo Endosurgery, Inc. (NASDAQ:APEN) has scheduled a conference call for 4th August 2020 at 4:30 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.apolloendo.com
Earnings Expectation
Apollo Endosurgery, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, APEN is expected to report 2Q20 loss of $ 0.33 per share from revenue of $ 5.19 million.
For the full year, analysts anticipate top line of $ 34.89 million, while looking forward to loss of $ 1.36 per share bottom line.
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing System that enables advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope; Orbera365 Managed Weight Loss System; and the BIB for the treatment of overweight and obese adults. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries.
